Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,014,503 papers from all fields of science
Search
Sign In
Create Free Account
Gastric irritation
Known as:
IRRITATION GASTRIC
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
18 relations
Abdominal discomfort
DISTRESS EPIGASTRIC
Gastroenteritis
Heartburn
Expand
Broader (5)
Abdominal distress
Abdominal distress/pain as reason for lower g.i. examination
Abdominal distress/pain as reason for upper g.i. examination
Gastrointestinal Diseases
Expand
Narrower (4)
Dyspepsia
EPIGASTRIC BURNING
Upset stomach
acid indigestion
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Preparation and Optimization of Triptolide-Loaded Solid Lipid Nanoparticles for Oral Delivery with Reduced Gastric Irritation
Cong Zhang
,
Conghui Gu
,
+5 authors
Xiangliang Yang
Molecules
2013
Corpus ID: 9562338
Triptolide (TP) often causes adverse reactions in the gastrointestinal tract when it is administered orally. This study aimed to…
Expand
2012
2012
P1.1.1 Voltammetric biosensors for the determination of paracetamol at carbon nanotube modified pyrolytic graphite electrode
R. Goyal
,
V. Gupta
,
Sukumar Chatterjee
2012
Corpus ID: 56266530
In this paper, we describe the research and development of a method of analysis for the determination of paracetamol by square…
Expand
2005
2005
Protective Effect of Melatonin and Omeprazole Against Alendronat-Induced Gastric Damage
G. Şener
,
Figen Onuk Goren
,
N. Ulusoy
,
Y. Ersoy
,
S. Arbak
,
Gól Ayanoĝlu Dólger
Digestive Diseases and Sciences
2005
Corpus ID: 23615944
Alendronate causes serious gastrointestinal adverse effects. We aimed to investigate if free radicals have any role in the damage…
Expand
1996
1996
Local tissue tolerability of meloxicam, a new NSAID: indications for parenteral, dermal and mucosal administration.
P. Stei
,
B. Kruss
,
J. Wiegleb
,
V. Trach
British Journal of Rheumatology
1996
Corpus ID: 26045271
Meloxicam is a new non-steroidal anti-inflammatory drug (NSAID) which has potent anti-arthritic activity and a reduced potential…
Expand
1994
1994
The central connections of the vagus nerve in the ferret
A. Knox
,
N. Strominger
,
A. Battles
,
D. Carpenter
Brain Research Bulletin
1994
Corpus ID: 21373505
1986
1986
Etodolac compared with aspirin: an endoscopic study of the gastrointestinal tracts of normal volunteers.
F. Lanza
,
J. Panagides
,
I. Salom
Journal of Rheumatology
1986
Corpus ID: 41500118
Forty-eight normal men participated in a 14-day, single blind, single center, multiple dose study of gastric irritation using…
Expand
1980
1980
Pharmacological studies in the rat with [2-(2,3-didecanoyloxy)-propyl]2-acetyloxybenzoate (A-45474): An aspirin pro-drug with negligible gastric irritation
G. Carter
,
P. Young
,
L. Swett
,
G. Y. Paris
Agents and Actions
1980
Corpus ID: 8140911
A triglyceride of aspirin, A-45474: [2-(1,3-didecanoyloxy)-propyl]2-acetyloxybenzoate, was developed to reduce the direct gastric…
Expand
1966
1966
Effect of aspirin on explanted gastric mucosa
F. Stephens
,
G. Milton
,
J. Loewenthal
Gut
1966
Corpus ID: 30479082
Naturally occurring salicylates existing in a great variety of plants have been used as medical remedies over the centuries by…
Expand
1960
1960
Comparative effect of acetylsalicylic acid and acetylsalicylic acid anhydride on the nonglandular portion of the rat stomach.
J. Gray
,
P. M. Jones
,
E. Feenstra
Toxicology and Applied Pharmacology
1960
Corpus ID: 46326776
1950
1950
Sodium Gentisate in the Treatment of Acute Rheumatic Fever
L. Schaefer
,
IRA A. RASHKOFF
,
RAYMOND S. MEGIBOW
Circulation
1950
Corpus ID: 33206778
Five patients with acute rheumatic fever were treated with gentisate, the biologic oxidation product of salicylate. The clinical…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE